HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Song Selected Research

Fetal Erythroblastosis (Erythroblastosis Fetalis)

4/2022[The Correlation Analysis between the Titer of IgG Anti-A/B Erythrocyte Antibody In Vivo of the Neonate and the Severity of Hemolytic Disease of Newborn].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Song Research Topics

Disease

64Neoplasms (Cancer)
10/2022 - 06/2002
21Inflammation (Inflammations)
06/2022 - 03/2008
15Neoplasm Metastasis (Metastasis)
10/2022 - 03/2008
12Fibrosis (Cirrhosis)
10/2021 - 06/2004
10Infections
04/2022 - 05/2005
10Breast Neoplasms (Breast Cancer)
12/2017 - 01/2013
9Body Weight (Weight, Body)
09/2019 - 12/2003
8Nasopharyngeal Carcinoma
01/2022 - 03/2008
7Stomach Neoplasms (Stomach Cancer)
10/2022 - 02/2014
7Glioblastoma (Glioblastoma Multiforme)
05/2022 - 12/2017
7Glioma (Gliomas)
01/2021 - 11/2011
7Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020 - 05/2009
6Schizophrenia (Dementia Praecox)
06/2022 - 05/2009
6Hypertension (High Blood Pressure)
01/2021 - 12/2003
5Neuroinflammatory Diseases
01/2021 - 04/2010
5Carcinogenesis
11/2020 - 02/2014
5Wounds and Injuries (Trauma)
10/2019 - 01/2017
5Alcoholic Cardiomyopathy
01/2011 - 07/2008
4Lung Neoplasms (Lung Cancer)
02/2022 - 01/2020
4Obesity
01/2022 - 09/2016
4Chondrosarcoma
01/2019 - 05/2015
4Multiple Sclerosis
08/2018 - 05/2009
4Leukemia
10/2014 - 10/2011
4Lung Injury
08/2012 - 03/2011
3Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 09/2013
3Hemolysis
04/2022 - 06/2009
3Adenocarcinoma of Lung
01/2022 - 05/2014
3Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 08/2008
3Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 06/2011
3Aortic Dissection
01/2021 - 10/2017
3Prolactinoma (Prolactinomas)
01/2021 - 01/2017
3Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2017
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 03/2004
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017 - 02/2015
3Diabetes Mellitus
01/2015 - 12/2003
3Constipation
01/2006 - 12/2003
2Asthma (Bronchial Asthma)
11/2022 - 12/2018
2AIDS-Related Complex (ARC)
06/2022 - 03/2016
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 01/2022
2Non-alcoholic Fatty Liver Disease
01/2022 - 09/2019
2Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 10/2020
2Carcinoma (Carcinomatosis)
01/2022 - 01/2017
2monomelic Amyotrophy
09/2021 - 08/2018
2Intervertebral Disc Degeneration
05/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
04/2022 - 02/2004
14Pharmaceutical PreparationsIBA
10/2022 - 09/2008
7TubulinIBA
10/2022 - 10/2017
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 10/2011
6LipidsIBA
01/2021 - 11/2017
6Matrix Metalloproteinases (MMPs)IBA
11/2020 - 01/2010
6Long Noncoding RNAIBA
11/2020 - 09/2013
6Messenger RNA (mRNA)IBA
10/2018 - 03/2004
5Particulate MatterIBA
11/2022 - 11/2021
5CytokinesIBA
06/2022 - 05/2019
5Circular RNAIBA
05/2022 - 01/2018
5Biological ProductsIBA
03/2022 - 09/2015
5EnzymesIBA
01/2022 - 08/2008
5Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2020
5C-Reactive ProteinIBA
03/2019 - 03/2008
4Air Pollutants (Pollutants, Air)IBA
11/2022 - 12/2021
4Hormones (Hormone)IBA
11/2021 - 08/2015
4Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 05/2016
4Laminin (Merosin)IBA
01/2020 - 05/2009
4Epidermal Growth Factor (EGF)IBA
01/2017 - 03/2008
4ErbB Receptors (EGF Receptor)IBA
01/2017 - 03/2008
4Interleukin-6 (Interleukin 6)IBA
10/2016 - 11/2002
3ColchicineFDA LinkGeneric
10/2022 - 10/2017
3LigandsIBA
01/2022 - 01/2014
3ApolipoproteinsIBA
01/2022 - 11/2009
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 07/2008
3Transcription Factors (Transcription Factor)IBA
06/2021 - 04/2010
3RubidiumIBA
02/2021 - 09/2019
3Indicators and Reagents (Reagents)IBA
01/2021 - 03/2014
3MicroRNAs (MicroRNA)IBA
01/2021 - 09/2015
3Protein Isoforms (Isoforms)IBA
01/2018 - 05/2009
3Nerve AgentsIBA
08/2012 - 07/2011
3Therapeutic UsesIBA
11/2011 - 11/2008
3PPAR alphaIBA
01/2011 - 07/2008
2Tubulin ModulatorsIBA
08/2022 - 07/2021
2ProdrugsIBA
06/2022 - 01/2021
2LipopolysaccharidesIBA
06/2022 - 03/2018
2ElementsIBA
06/2022 - 01/2016
2Nitrogen DioxideIBA
06/2022 - 12/2021
2OzoneIBA
06/2022 - 12/2021
2RNA-Binding Proteins (RNA-Binding Protein)IBA
05/2022 - 11/2020
2LuciferasesIBA
04/2022 - 01/2020
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2022 - 05/2015
2HydrogelsIBA
01/2022 - 02/2021
2SugarsIBA
01/2022 - 01/2016
2AntigensIBA
11/2021 - 01/2021
2Toll-Like Receptor 4IBA
10/2021 - 10/2020
2ChemokinesIBA
09/2021 - 02/2015
2GelsIBA
02/2021 - 09/2019

Therapy/Procedure

36Therapeutics
10/2022 - 05/2003
9Drug Therapy (Chemotherapy)
02/2022 - 05/2015
4Immunotherapy
01/2021 - 01/2015
4Radiotherapy
01/2021 - 05/2015
2Radiofrequency Ablation
02/2022 - 01/2021
2Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2021 - 02/2015